CLINICAL_TRIALS ClinicalTrials.gov record update

Phase IIIb, Multicentre Study to Assess Safety & Immunogenicity of GSK Biologicals' Combined DTPa/Hib (Infanrix/Hib) Vaccine vs Separate Administration of DTPa (Infanrix) & Hib (Hiberix) Vaccines in Healthy Infants 3,4,&5 Months of Age as Compared With the Separate Administration of DTPa and Hib Vaccines at Different Injection Sites.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00412854
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:54.762990+00:00
Published At: 2017-02-10T00:00:00+00:00
Record Updated At: 2018-06-06
Results Posted At: 2017-02-10
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Tetanus", "Diphtheria", "Acellular Pertussis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-06-06"
protocolSection.identificationModule.nctId: "NCT00412854"
protocolSection.identificationModule.officialTitle: "Phase IIIb, Multicentre Study to Assess Safety \u0026 Immunogenicity of GSK Biologicals\u0027 Combined DTPa/Hib (Infanrix/Hib) Vaccine vs Separate Administration of DTPa (Infanrix) \u0026 Hib (Hiberix) Vaccines in Healthy Infants 3,4,\u00265 Months of Age as Compared With the Separate Administration of DTPa and Hib Vaccines at Different Injection Sites."
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2017-02-10"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.